First Allied Advisory Services’s Novavax NVAX Stock Holding History

First Allied Advisory Services’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-7,025	Closed	-$77K	–	1230
2019 Q1	$77K	Hold	7,025	–	–	﹤0.01%	1124
2018 Q4	$259K	Hold	7,025	–	–	0.01%	840
2018 Q3	$264K	Buy	7,025 +2,000	+40%	+$56.3K	0.01%	968
2018 Q2	$135K	Buy	5,025 +2,000	+66%	+$67.6K	0.01%	1096
2018 Q1	$127K	Buy	3,025 +25	+0.8%	+$1K	﹤0.01%	1116
2017 Q4	$74K	Hold	3,000	–	–	﹤0.01%	1242
2017 Q3	$68K	Buy	+3,000	New	+$67.2K	﹤0.01%	1097
2016 Q3	–	Sell	-513	Closed	-$75K	–	1080
2016 Q2	$75K	Hold	513	–	–	﹤0.01%	1011
2016 Q1	$53K	Buy	513 +10	+2%	+$1.07K	﹤0.01%	983
2015 Q4	$85K	Buy	+503	New	+$77.4K	﹤0.01%	1059
2015 Q1	–	Sell	-1,175	Closed	-$140K	–	1115
2014 Q4	$140K	Buy	1,175 +605	+106%	+$63.2K	0.01%	974
2014 Q3	$50K	Buy	+570	New	+$51.5K	﹤0.01%	1011

Other funds holding NVAX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

First Allied Advisory Services's NVAX Position: Q2 2019 in Review

First Allied Advisory Services sold out of Novavax (NVAX) in Q2 2019, closing a stake of 7,025 shares — an estimated $77K sold.

First Allied Advisory Services first reported a position in NVAX in Q3 2014 and held it in 12 quarters. The position peaked at $264K in Q3 2018. 81 funds tracked by Wall St. Rank hold NVAX as of Q2 2019.

First Allied Advisory Services reported no remaining Novavax position as of Q2 2019 after selling out during the quarter.
First Allied Advisory Services sold 7,025 Novavax shares in Q2 2019, an estimated $77K.
First Allied Advisory Services first reported a position in Novavax in Q3 2014 and held it in 12 quarters.
First Allied Advisory Services's Novavax position peaked at $264K in Q3 2018.
81 funds tracked by Wall St. Rank held Novavax as of Q2 2019.

Based on First Allied Advisory Services's 13F filing for Q2 2019, filed 12 Aug 2019.